Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Notice of intent: Exempting nicotine tablets from the Prescription Drug List Date: July 14, 2025 Our file number: 25-104457-17 The purpose of this notice of intent is to announce that Health Canada will add a new part "g" to the qualifier of the "Nicotine or its salts" listing on…
Notice of intent: Revisions to the Prescription Drug List for nicotine buccal pouches Date: July 14, 2025 Our file number: 25-104457-17 The purpose of this notice of intent is to announce that Health Canada will revise the qualifier of the “Nicotine or its salts” listing on the…
Acetaminophen with codeine or oxycodone in short supply: Notice Date published: July 21, 2025 Date updated: February 20, 2026 On this page Background What we're doing What you can do Background Drugs that contain acetaminophen with codeine or with oxycodone are used to relieve…
Notice of amendment: Nicotine tablets exempted from the Prescription Drug List Date: July 21, 2025 Our file number: 25-104457-17 The purpose of this notice of amendment is to announce that Health Canada has added a new part to the qualifier of the "Nicotine or its salts" listing…
Dantrolene Sodium for Injection supply in Canada: Notice Date published: July 21, 2025 Date updated: October 31, 2025 On this page Background What we're doing What you can do Background Dantrolene Sodium for Injection is used in hospitals to manage malignant hyperthermia crisis,…
Notice: Spironolactone in short supply On this page Background What we're doing What you can do Background Spironolactone is a drug used in the diagnosis of primary hyperaldosteronism. It is also used in the treatment of nephrotic syndrome, hypertension, hypokalemia, and…
Nitrosamine impurities in medications: Guidance Overview Recalls Test methods and test results Guidance Established acceptable intake limits Report a problem or concern Download in PDF format (1.37 MB, 52 pages) Organization: Health Canada Date published: 2022-04-04 Date updated:…
Qualifying notice for Braftovi (292474) Pharmaceutical Drugs Directorate Holland Cross, Tower "B" 6th Floor, 1600 Scott Street Address Locator number 3106B Ottawa ON K1A 0K9 Dossier ID: e224354 Control number: 292474 [name of employee removed] Manager, Regulatory Sciences Pfizer…
Notice: Classification of topical products containing human-derived exosomes, human extracellular vesicles, and/or human cell-conditioned media August 14, 2025 Our file number: 25-104893-244 Classification is the first step in any regulatory process at Health Canada. The Food and…
Notice: Multiple additions to the Prescription Drug List (PDL) [2025-08-28] August 28, 2025 Our file number: 25-105622-852 The purpose of this Notice of Amendment is to announce the addition of artesunate, crovalimab, osilodrostat, and quizartinib to the Prescription Drug List…
Early release: coverage and features are still expanding.
